Selecting the right research site is one of the most important decisions in a clinical trial startup. A well-chosen site does more than just provide a location—it serves as a strategic link to a partnership that streamlines operations, expedites approvals, and keeps patient enrollment on track.
Clinical trial startup is a complex process involving contract approvals, IRB submissions, patient recruitment plans, prescreening, feasibility, study staff training, vendor management, and patient and provider engagement—each of which can introduce delays if not managed efficiently. The right site offers efficiency for every phase, activating trials faster and moving swiftly toward execution.
Every clinical trial starts with site selection, but this choice extends far beyond just finding a site with available space and equipment. A well-qualified site must have:
A site’s ability to streamline startup activities directly impacts activation timelines. Here’s how the right site can help:
Contract delays are one of the most common reasons clinical trials fall behind schedule. A strong site will:
Without an efficient site: Contract negotiations can stall for months, delaying site activation and increasing costs.
IRB approvals are a critical regulatory checkpoint that must be cleared prior to patient recruitment. A site with strong regulatory expertise will:
Without an efficient site: Incomplete submissions or delayed responses to IRB inquiries can push back study activation by weeks or even longer.
At the risk of stating the obvious, without patients, a trial cannot proceed. The right site has the tools and experience to identify, recruit, and enroll participants efficiently:
Without an efficient site: Enrollment targets may not be met, requiring costly protocol amendments or site expansions.
Enrolling a patient is just the first step—keeping them engaged is equally important. A patient-centric site will:
Without an efficient site: High dropout rates can compromise data integrity and require additional recruitment efforts, delaying trial timelines.
At Remington-Davis, we specialize in efficient, patient-centric clinical trial startups. Sponsors and contract research organizations (CROs) trust us to:
When you partner with Remington-Davis, you will have a strategic partner committed to driving trial success from day one.
A clinical trial startup is only as strong as the site leading it. With Remington-Davis, sponsors and CROs eliminate inefficiencies, reduce delays, and accelerate the activation process.
Optimize your next trial startup with an experienced team. Contact us today to learn how we can help.
Finding appropriate sites requires an understanding of factors like site performance metrics, regulatory expertise, patient recruitment capabilities, and retention rates. Sponsors should look for sites with a track record of fast activation, access to a diverse patient population, and strong infrastructure for electronic data management. On-site visits are also an important factor in gauging a site’s infrastructure and capability.
Regulatory bodies require complete and accurate information at every stage of clinical trial startup to avoid approval delays. Essential submission documents typically include the study protocol, investigator brochures, informed consent forms, site selection criteria, and patient recruitment strategies. A well-prepared study site ensures all necessary documentation is submitted error-free and on time.
Sites that utilize advanced clinical trial management systems (CTMS) and electronic trial master files (eTMF) minimize the risk of data loss that could delay study activation. With real-time data access, automated backups, and secure digital infrastructure, a tech-forward trial site keeps study startup activities running smoothly and stakeholders aligned.